Emily McCord
Family · Bessemer, ALNPI 1922799766
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.5% of the total across 118 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 17 manufacturers, the largest accounting for just 15.2% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $2,764, more than ten times the $20 reported in 2023.
Across 118 payments — averaging $24.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$433
- Regeneron Healthcare Solutions, Inc.$329
- Novartis$326
- Sanofi$299
- AbbVie$279
- Pfizer$219
- plus $956 from 11 others
What the payments were for
- Food & beverage$2,74196%
- Education$1004%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 13 | $433 |
| Regeneron Healthcare Solutions, Inc. | 7 | $329 |
| Novartis | 21 | $326 |
| Sanofi | 8 | $299 |
| AbbVie | 22 | $279 |
| Pfizer | 9 | $219 |
| Galderma Laboratories, L.p. | 13 | $198 |
| Amgen | 4 | $179 |
| UCB, Inc. | 6 | $170 |
| Mayne Pharma Commercial LLC | 4 | $111 |
| Sun Pharmaceutical Industries Inc. | 2 | $80 |
| Arcutis Biotherapeutics, Inc. | 2 | $60 |
| Regeneron | 1 | $51 |
| Organon | 3 | $42 |
| Lilly USA, LLC | 1 | $24 |
| LEO Pharma Inc. | 1 | $20 |
| Incyte Corporation | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,841 in reported general payments places this provider in the 80th percentile of 3,415 family providers in Alabama.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Albuterol Sulfate HfaAlbuterol Sulfate | 13 | $269 |
| Doxycycline Hyclate | 32 | $260 |
| Fluticasone Propionate | 14 | $164 |
| Cephalexin | 22 | $148 |
| Cefdinir | 11 | $120 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 11 | $92 |
| Methocarbamol | 36 | $87 |
| Ondansetron OdtOndansetron | 12 | $65 |
| Meloxicam | 25 | $22 |
Paid to pharmacies, not to this prescriber.
Other family in Bessemer
- Jessie CorreaBessemer$12K
- Leigh Ann ChildressHuntsville$240K
- Molly ReevesAuburn$158K
- Christina CanteyHuntsville$118K
- Leigh LunaMontgomery$69K
- Christopher LovellMobile$64K
- Justin SimpsonTuscaloosa$43K
- Kellyn McMahonBirmingham$39K
- Ashley StinesTuscaloosa$29K
- Brandy YoungMontgomery$27K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.